MedPath

Substitution of pure fruit juice with sugar-sweetened beverages and fruit and cardiometabolic risk.

Recruiting
Conditions
Type 2 diabetes, cardiovascular diseases
Registration Number
NL-OMON21084
Lead Sponsor
etherlands Organisation for Scientific Research (NWO), Dutch Ministry of Health, Welfare and Sports (VWS), the Netherlands Organisation for Health Research and Development (ZonMW), World Cancer Research Fund (WCRF), European Commission (DG SANCO)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
37000
Inclusion Criteria

The EPIC-NL study consists of two cohorts: the MORGEN cohort and the Prospect cohort. The MORGEN cohort consists of men and women aged 20 – 65 years selected from random samples of the Dutch population in three towns in the Netherlands (Amsterdam, Doetinchem, Maastricht). The Prospect cohort consists of women, from the Dutch town Utrecht or its vicinity, who participated in a breast cancer screening program.

Exclusion Criteria

Prevalent diabetes or CVD, missing FFQ, implausible energy intake, missing follow-up, missing data on confounders.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cardiovascular diseases and type 2 diabetes
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath